Please assess the completion status of the following clinical trial:

Trial Title: Effect of Magnesium on Dose of Rocuronium for Deep Neuromuscular Blockade

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients who undergo elective robot assisted radical prostatectomy, between 20 and 80 years with a American Society of Anesthesiologists physical status classification of I or II~Exclusion Criteria:~* Conduction abnormalities in preoperative EKG such as Atrioventricular block, sinus pause~* Glomerular filtration rate \<60ml/min/1.73m2~* Allergy to rocuronium, sugammadex, magnesium~* Medications that interfered with muscle activity~* Neuromuscular disease~* Hypermagnesemia

- Gender: MALE
- Minimum Age: 20 Years
- Maximum Age: 80 Years
- Healthy Volunteers: t

Study Arms:
- Magnesium Sulfate group (Type: ACTIVE_COMPARATOR): magnesium sulphate 50mg/kg in normal saline 50ml infusion for 10minutes for loading dose followed by 15mg/kg/hr for continuous infusion
- Placebo group (Type: PLACEBO_COMPARATOR): Normal Saline 50ml infusion for loading dose followed by continuous infusion for same dose of magnesium.

Based on this trial design, predict the completion outcome and termination type (if applicable).